Related Experiment Video
Updated: Feb 1, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Emerging roles of proteoglycans in cardiac remodeling
Xiaoya Wang1, Yi Lu1, Yao Xie1
1Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang 310009, PR China.
Insights
Proteoglycans, key extracellular matrix components, significantly modify cardiac remodeling in response to heart disease. Targeting proteoglycans offers potential therapeutic strategies for cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Extracellular Matrix Research
Background:
- Cardiac remodeling is the heart's adaptive response to pathological stimuli, which can lead to adverse clinical outcomes if sustained.
- Hallmarks of cardiac remodeling include cardiomyocyte loss or hypertrophy, inflammation, and fibrosis.
- Proteoglycans are extracellular matrix components crucial for cardiovascular development and function.
Purpose of the Study:
- To investigate the role of proteoglycans in cardiac remodeling.
- To explore the potential of proteoglycans as therapeutic targets for cardiovascular diseases.
Main Methods:
- Review of existing literature on proteoglycans and cardiac remodeling.
- Analysis of studies investigating proteoglycan function in models of cardiac stress (ischemia, pressure overload).
Main Results:
- Proteoglycan deficiency leads to developmental cardiovascular defects.
- Proteoglycans significantly modulate cardiac remodeling in response to ischemia and pressure overload.
- Emerging evidence highlights proteoglycans' role in pathological cardiac remodeling.
Conclusions:
- Proteoglycans are critical regulators of cardiac remodeling.
- Modulating proteoglycan function presents a promising therapeutic avenue for cardiovascular diseases.
- Further research into proteoglycans could improve cardiovascular disease prognosis.
Abstract:
Cardiac remodeling is the response of the heart to a range of pathological stimuli. Cardiac remodeling is initially adaptive; however, if sustained, it ultimately causes adverse clinical outcomes. Cardiomyocyte loss or hypertrophy, inflammation and fibrosis are hallmarks of cardiac remodeling. Proteoglycans, which are composed of glycosaminoglycans and a core protein, are a non-structural component of the extracellular matrix. The lack of proteoglycans results in cardiovascular defects during development. Moreover, emerging evidence has indicated that proteoglycans act as significant modifiers in ischemia and pressure overload-related cardiac remodeling. Proteoglycans may also provide novel therapeutic strategies for further improvement in the prognosis of cardiovascular diseases.
More Related Videos
Related Concept Videos
Introduction Cardiac Emergencies
Proteoglycans
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Matrix Proteoglycans and Glycoproteins
Emerging Adulthood
Bone Remodeling

